Cancer Topics
The On-Topic Netowork

Cancer > Angiogenesis Inhibitor

The following information is about Angiogenesis Inhibitor.

Angiogenesis Inhibitor Defined

A substance that may prevent the formation of blood vessels. In anticancer therapy, an angiogenesis inhibitor prevents the growth of blood vessels from surrounding tissue to a solid tumor.

This definition is in context to Cancer. See more contextual defintions for Angiogenesis Inhibitor.


2009 Dr. Paul Janssen Award For Biomedical Research Won By Axel Ullrich

Published July 2, 2009, 8:09 am, Medical News Today

Johnson & Johnson has announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin® (trastuzumab) , is the winner of the 2009 Dr. Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists selected Dr.

Full Story


Pfizer Discontinues Phase 3 Trial Of Sutent(R) In Metastatic Colorectal Cancer

Published July 2, 2009, 4:09 am, Medical News Today

Pfizer Inc announced the discontinuation of the SUN 1122 Phase 3 trial that evaluated Sutent® (sunitinib malate) plus FOLFIRI (irinotecan plus infusional 5-fluorouracil and leucovorin) versus FOLFIRI alone for the first-line treatment of metastatic colorectal cancer (CRC).

Full Story


02.07.2009 - DJ DGAP-Adhoc: TopoTarget completes fully subscribed rights issue

Published July 2, 2009, 12:44 am, 4investors

Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. =--------------------------------------------------------------------------

Full Story


Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research

Published July 1, 2009, 11:30 am, redOrbit

LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin(R) (trastuzumab)*, is the winner of the 2009 Dr.

Full Story


Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research

Published July 1, 2009, 10:14 am, EurekAlert!

( Porter Novelli ) Johnson & Johnson announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin (trastuzumab), is the winner of the 2009 Dr. Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists ...

Full Story


Are you looking for additional Cancer > Angiogenesis Inhibitor news? Try our new "Angiogenesis Inhibitor News Focus" area.

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Angiogenesis Inhibitor. If you would like to find related tags we recommend Tag Patterns > Angiogenesis Inhibitor

Off-site Angiogenesis Inhibitor Research Links

If you still need additional information on Angiogenesis Inhibitor then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Cancer

If you know the Cancer Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

License

Creative Commons License This work is licensed under Creative Commons.


Your Ad Here
Your Ad Here

Powered by Odin Assemble 2.5a